In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on Boston Scientific (BSX – Research Report), with a ...
Raymond James analyst Jayson Bedford raised the firm’s price target on Boston Scientific (BSX) to $122 from $119 and keeps a Strong Buy rating ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback